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Introduction
Neural tube defects (NTDs) have an incidence of 1–2
per 1,000 births and are considered to be a heteroge-
neous condition resulting from failure of normal neu-
ral tube closure between the third and fourth week of
embryonic development. The three common types of
NTDs are anencephaly, spina bifida, and encephalo-
cele. The uncommon types of NTDs include amniotic
band syndrome, limb–body wall complex, cloacal
exstrophy or OEIS complex, and other types of spinal
abnormalities. The incidence of NTDs varies with race,
geographic variation, socioeconomic classes, nutri-
tional status, and multiple predisposing factors such
as single gene disorders, chromosomal abnormalities,
teratogens, maternal diabetes, family history of NTDs,
thermolabile mutation in the MTHFR gene, and others
[1]. There is considerable evidence that genetics and
environmental factors contribute to the etiology of
NTDs. Fetuses with NTDs may be associated with syn-
dromes, disorders, and maternal risk factors.
Acrocallosal Syndrome (ACLS)
ACLS (OMIM 200990) is characterized by hallux dupli-
cation, postaxial polydactyly of hands and feet, hypoplas-
tic or absent corpus callosum, macrocephaly, and
severe mental retardation [2]. ACLS has an autosomal
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recessive inheritance pattern. However, some cases of
ACLS can be caused by mutations in the GLI3 gene
(OMIM 165240) [3]. Pfeiffer et al [4] reported a case
of ACLS associated with a de novo inverted tandem
duplication of 12p11.2–p13.3. The brain defects of
ACLS include hypoplastic or absent corpus callosum,
intracranial cysts, polymicrogyria, cerebral atrophy,
hypothalamic dysfunction, hypoplastic pons, medulla
oblongata and cerebellar hemispheres, small cerebel-
lum, agenesis or hypoplasia of cerebellar vermis, and
anencephaly [5]. Anencephaly is the severe end of the
spectrum of the brain defects in ACLS. Gelman-Kohan
et al [6] first reported anencephaly in only one of four
cases with ACLS. Cataltepe and Tuncbilek [7] reported
a Turkish family with parental consanguinity, one child
with ACLS, and one child with anencephaly and poly-
dactyly, and suggested that anencephaly is the extreme
of the central nervous system malformations associ-
ated with ACLS. Lurie et al [8] reported a family with
ACLS in a female proband and anencephaly in her 
sister, and suggested that anencephaly is an extreme
manifestation of ACLS-related brain defects. Kedar 
et al [9] reported recurrent anencephaly as a primary
manifestation of ACLS in a consanguineous Arab fam-
ily. Christensen et al [10] reported a consanguineous
Norwegian family with two pregnancies (male and
female) affected with anencephaly, median cleft lip
and palate, omphalocele, and preaxial polydactyly,
suggesting the diagnosis of ACLS.
Autosomal Dominant Brachydactyly-
clinodactyly Syndrome
Stagiannis et al [11] reported exencephaly in a 17-
week gestation female fetus with abnormalities of the
hands and a family history suggestive of brachydactyly
syndrome type C or autosomal dominant brachydactyly-
clinodactyly syndrome. Brachydactyly syndrome type C
(OMIM 113100) is caused by mutations in the
growth/differentiation factor-5 (GDF5) gene (OMIM
601146).
Manouvrier Syndrome
Manouvrier et al [12] reported a multiple congenital
anomalies syndrome in a family with four affected
females with radial ray malformation (preaxial hand
anomalies and radioulnar synostosis), and a 14-week
gestation male fetus with severe radial ray malformation,
anencephaly, unilateral renal agenesis, and a common
dorsal mesentery. The report of the affected mother
and fetus suggested that this multiple congenital
anomalies syndrome could represent a new X-linked
dominant multiple congenital anomalies syndrome or
an autosomal dominant condition with severe expres-
sion limited to males [12].
Short Rib–Polydactyly Syndrome (SRPS)
SRPSs are a heterogeneous group of lethal autosomal
recessive skeletal dysplasias. Four types of SRPSs have
been recognized [13]. Type I SRPS (Saldino-Noonan;
OMIM 263530) is characterized by flipper-like extrem-
ities, polydactyly, polycystic kidneys, and pointed
metaphyses. Type II SRPS (Majewski; OMIM 263520)
is characterized by polydactyly, micromelia, cleft
lip/palate, polycystic kidneys, disproportionately short
ovoid tibia, and occasionally, hypoplastic epiglottis
and larynx. Type III (Verma-Naumoff; OMIM 263510)
is characterized by polydactyly, micromelia, metaphyseal
spurs, and occasionally, situs inversus totalis. Type IV
SRPS (Beemer-Langer; OMIM 269860) clinically resem-
bles type II SRPS other than the polydactyly.
Overlapping in the clinical and radiologic manifestations
has led to the hypothesis that the different subtypes
may be a single genetic disorder with variable expres-
sivity [14–17]. Martínez-Frías et al [18] reported two
patients with SRPS from two unrelated Spanish fami-
lies. One patient had anencephaly, and the other
patient had severe brain abnormalities with a family
history of an older sister with anencephaly and a
brother with SRPS.
A Human Homologue of the Mouse
Mutant Disorganization (Ds)
Birth defects resembling the mouse mutant gene
Disorganization (Ds) or Ds-like human malformations
(OMIM 223200) include both common (NTDs, orofa-
cial clefting, gastroschisis and limb defects) and rare
(anophthalmia and duplicated rectum) human birth
defects [19]. In mice with Ds mutations, the defects
involve duplications, aplasia or atresia, malformations,
malposition, retention of embryonic structures, and
hamartomas. Many Ds-like human malformations have
been reported [19]. ten Donkelaar et al [20] reported
a 5-month-old boy with distal transverse defects of
both hands, congenital scalp defects, and intestinal
mucosa on top of a rudimentary occipital meningocele
in amniotic rupture sequence, and suggested a possible
Ds-like syndrome. Corona-Rivera et al [21] reported 
a female infant with non-anatomic lumbopedal union
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by a skin pedicle, anorectal malformation, meningo-
cele, vertebral segmentation defects, longitudinal limb
defects, and vestigial feet and skin papillae, and sug-
gested that Ds-like mutations may cause some cases 
of apparent amniotic band syndrome associated with
skin pedicles.
Isolated Hemihyperplasia
Isolated hemihyperplasia (OMIM 235000) or hemi-3
syndrome (hemihypertrophy, hemihypoesthesia, and
hemiareflexia) is characterized by asymmetric over-
growth of one or more regions of the body due to an
abnormality of cell proliferation. The responsible gene
maps to chromosome 11p15. Nudleman et al [22]
reported three unrelated girls with hemi-3 syndrome and
scoliosis, one of whom had a lumbar myelomeningo-
cele, and all three had a family history of neural tube
closure defects.
X-linked NTDs
X-linked NTDs (OMIM 301410) have been previously
regarded as an X-linked recessive inheritance by the
clinical observations in different families and genera-
tions that were genealogically connected through
females and had only males affected with NTDs
[23–26]. Using linkage analysis, Newton et al [27] and
Hol et al [28] excluded the X chromosome and sug-
gested that the susceptibility gene may map elsewhere
on one the autosomes. Plaja et al [29] reported an
anencephalic fetus with acrania, cervicodorsal rachis-
chisis, a left diaphragmatic hernia, ipsilateral lung
hypoplasia, intestinal malrotation, horseshoe kidneys,
adrenal gland hypoplasia, del(X)(p22.1 pter), and
the karyotype of 46,X,del(X)(p22.1). Fryns et al [30]
reported a spina bifida case with a de novo X/autoso-
mal translocation of t(X;22)(q27;q12.1) pointing to a
possible causative gene in Xq27. Hol et al [31]
reported familial duplication of Xq26–q27 in two
brothers, their mother, and their grandmother. The first
brother had lower lumbar spina bifida occulta and deep
sacral dimples, and the second brother had a large
lumbosacral meningomyelocele. Cytogenetic analysis
revealed the karyotype of 46,XY, dup(X)(q26q27), and
fluorescence in situ hybridization analysis revealed that
the duplication extended from Xq26.1 to Xq27.3. Hol
et al [31] suggested that the two brothers had NTDs
that were due to an interruption of a critical gene in
the region of the Xq27 breakpoint, and narrowed the
interval to Xq27.3 between DXS369 and DXS1200.
Meroanencephaly
Meroanencephaly is characterized by malformed cra-
nial bones and a median cranial defect with a midline
frontal mass composed of area cerebrovasculosa,
which contains both vascular and glial tissues [32].
Zhao et al [33] found that cartilage homeoprotein
(CART1; OMIM 601527) is selectively expressed in
chondrocytes. Gordon et al [34] mapped the CART1
gene to chromosome 12q21.3–q22. Zhao et al [35]
found that mice homozygous for deficiency in the
Cart1 gene manifested acrania and meroanencephaly,
and prenatal treatment with folic acid will suppress
acrania and meroanencephaly in the Cart1-deficient
mutants.
Schisis Association
Czeizel [36] first proposed the schisis association of 
a combination of two or more schisis defects such as
NTDs (anencephaly, encephalocele, and spina bifida),
omphalocele, diaphragmatic defects (diaphragmatic
hernia or agenesis of diaphragm), and cleft lip and/
or cleft palate. Czeizel [36] observed that 0.29%
(130/44,608) of malformed infants had two or more
schisis defects without other major congenital malfor-
mations, and the most frequent combination of the
schisis defects was anencephaly with cleft lip and/or
cleft palate (33 cases out of 130 cases). Martínez-Frías
et al [37] observed that 0.09% (20/22,264) of live and
stillborn malformed infants identified by the Spanish
Collaborative Study of Congenital Malformations had
two or more schisis defects and were not known to
have other major or minor defects, and the most fre-
quent associations were omphalocele with cleft palate
and/or cleft lip, and omphalocele with diaphragmatic
defects. Martínez-Frías et al [37] suggested that com-
binations of two schisis defects may represent blasto-
genetic sequences.
Diprosopus
Diprosopus is a rare form of conjoined twins consist-
ing of one neck, one body, and a single hand with vari-
ous forms of duplication of the craniofacial structures.
Diprosopus may be associated with anencephaly, cranio-
rachischisis, encephalocele, and spina bifida [38–50].
Changaris and McGavran [38] reported anencephaly,
cleft lip and palate, a ventricular septal defect, and an
atrial septal defect in a twin with diprosopus. Riccardi
and Bergmann [39] reported an anencephalic stillbirth
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with craniorachischisis and diprosopus and suggested
that the concurrence of NTDs and incomplete twin-
ning is due to a single pathogenetic mechanism com-
mon to both NTDs and monozygotic twinning. Barr
[40] reported a large frontal encephalocele and a ven-
tricular septal defect associated with diprosopus.
Moerman et al [41] reported a case of monocephalus
diprosopus with craniorachischisis and duplication of
most of the foregut and suggested that certain types of
incomplete twinning and NTDs may be caused by a
single teratogenic mechanism. Chervenak et al [42]
reported the prenatal diagnosis of hydrocephalus in a
37-week gestation fetus with lumbosacral meningomye-
locele, cleft lip and palate, and left diaphragmatic her-
nia associated with diprosopus, and suggested that
prenatal diagnosis of fetal hydrocephalus should
prompt a careful search for other anomalies, such as
diprosopus. Rydnert et al [43] reported a 20-week ges-
tation fetus with diprosopus and craniorachischisis.
Pavone et al [44] reported a case of diprosopus with
anencephaly and a case of diprosopus with cranio-
rachischisis, ventricular septal defects, and diaphrag-
matic hernia. Strauss et al [45] reported the prenatal
diagnosis of polyhydramnios, hydrocephalus, thora-
columbar spina bifida, and left diaphragmatic hernia in
a 20-week gestation fetus with diprosopus. Fontanarosa
et al [46] reported the first-trimester sonographic
diagnosis of diprosopus twins with craniorachischisis.
Sharony et al [47] reported an 18-week gestation fetus
with a left diaphragmatic hernia and thoracolumbar
spina bifida with meningocele, clubfeet, and ventricu-
lar septal defects. al Muti Zaitoun et al [48] reported 
a 33-week gestation fetus with diprosopus, cleft palate,
and craniorachischisis. Bulbul et al [49] reported 
a 14-week gestation fetus with increased nuchal translu-
cency, facial cleft, and a large lumbosacral spina bifida.
Ekinci et al [50] reported a 28-week gestation fetus with
anencephaly and diprosopus. Sharony et al [47] reviewed
11 reported cases of diprosopus and found that ten
cases had NTDs, six cases had congenital heart defects,
and four cases had diaphragmatic hernia.
Fetal Valproate Syndrome (FVS)
Fetuses exposed to sodium valproate, an antiepileptic
drug, are at risk of FVS. The NTDs associated with FVS
occur in the first trimester of pregnancy, as NTDs are
formed by day 28 after conception. FVS or valproate
embryopathy (OMIM 609442) is characterized by
facial features of trigonocephaly, a tall forehead with
bifrontal narrowing, epicanthic folds, an infraorbital
groove, medial deficiency of eyebrows, a flat nasal
bridge, a broad nasal root, anteverted nares, a shallow
philtrum, a long upper lip with thin vermilion border, 
a thick lower lip, and a small down-turned mouth
[51–54]. The most common major congenital malfor-
mations associated with FVS include NTDs, congenital
heart defects, cleft lip and palate, genitourinary mal-
formations, and radial ray defects, and the other less
frequent associated anomalies include abdominal wall
defects, tracheomalacia, strabismus, arachnodactyly,
and overlapping fingers [54]. The risk factors for the
teratogenicity of sodium valproate include the number
of drugs that are co-administered, the dosage of drug,
the differences in maternal and/or infant metabolism,
the fetal gestational age at exposure, and the heredi-
tary susceptibility [55]. Sodium valproate appears to
be associated with lower lumbar or sacral spina bifida
in humans [54]. The prevalence of spina bifida with
FVS is about 1–2%, a 10- to 20-fold increase in NTDs
[56]. The spina bifida in FVS is often skin-covered, and
the maternal serum α-fetoprotein level is often normal
[54]. Omtzigt et al [57] and Guibaud et al [58] sug-
gested that maternal serum α-fetoprotein levels may be
unreliable for prenatal screening of fetal NTDs in women
on sodium valproate medication, and recommended
amniocentesis and prenatal ultrasound for the detection
of spina bifida after first-trimester valproate exposure.
DiGeorge Syndrome (DGS)/
Velocardiofacial Syndrome (VCFS)
DGS (OMIM 188400)/VCFS (OMIM 192430) or
22q11.2 deletion syndrome is characterized by
hypocalcemia, parathyroid hypoplasia, thymic hypopla-
sia, conotruncal cardiac defects, and facial features of
a prominent tubular nose, narrow palpebral fissures
and a slightly retruded mandible. DGS/VCFS is caused
by a hemizygous deletion of chromosome 22q11.2 or
point mutations in the TBX1 gene. Haploinsufficiency
of the TBX1 gene (OMIM 602054) is responsible for
the physical malformations. Nickel et al [59] reported
three unrelated children with meningocele, of whom
one had DGS and two had with VCFS, and all were
with a 22q11.2 deletion. Seller et al [60] reported a
22-week gestation fetus with sacral spina bifida,
conotruncal cardiac defects, cleft palate, facial dys-
morphism, Kousseff syndrome, and del(22)(q11.2q11.2).
Forrester et al [61] studied the family described by
Kousseff [62] and found a deletion of chromosome
22q11–q13 in the proband, his diseased brother, and
his father. The proband, his brother, and his sister had
myelomeningocele and clinical findings consistent
with DGS/VCFS. Maclean et al [63] reported two cases
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of sacral meningomyelocele, conotruncal cardiac anom-
alies, Kousseff syndrome, and a 22q11.2 microdeletion,
and suggested that Kousseff syndrome is a distinct
clinical entity that is genetically heterogeneous.
Waardenburg Syndrome
Waardenburg syndrome type I (OMIM 193500), an
autosomal dominant disorder, is characterized by 
a wide bridge of the nose, lateral displacement of the
inner canthus of each eye, pigmentary disturbance of
frontal white blaze of hair, heterochromia iridis, white
eye lashes, leukoderma, and cochlear deafness, and is
caused by mutations in the PAX3 gene at chromosome
2q35. Waardenburg syndrome type III (OMIM
148820) is characterized by a more severe phenotype
of partial albinism, blue eyes, deaf-mutism, undevel-
oped muscles and fused joints in the arms, and skele-
tal dysplasia, and is caused by an allelic mutation in
the PAX3 gene or a contiguous gene syndrome because
of a deletion of the PAX3 gene and adjacent genes.
Waardenburg syndrome may be associated with
NTDs. Chatkupt et al [64] reported Waardenburg syn-
drome type I and myelomeningocele in a family. The
mother had Waardenburg syndrome, and her two
sons had both Waardenburg syndrome and lum-
bosacral myelomeningocele. Nye et al [65] reported
lumbosacral myelomeningocele and Waardenburg
syndrome type III in patients with an interstitial dele-
tion of 2q35 and the PAX3 gene. The PAX3 gene was
mapped to chromosome 2q35. Hol et al [66] reported
a girl with spina bifida, mild signs of Waardenburg
syndrome, and a frameshift mutation in the gene for
PAX3. Shim et al [67] reported a 6-year-old boy with
bilateral sensorineural deafness, lateral displacement of
inner canthi, a bulbous nasal tip, synophrys, cryptor-
chidism, Waardenburg syndrome type I, a lumbar spina
bifida, and the karyotype of 46,XY,der(2)inv(2)(q13q21) 
inv(2)(q21q24.2)ins(2)(q24.2q33q35). Fluorescence
in situ hybridization study showed a breakpoint at
2q35 being proximal to and without involvement of
the PAX3 gene. Kujat et al [68] reported the prenatal
diagnosis of spina bifida in a fetus, leading to the ini-
tial diagnosis of Waardenburg syndrome type I in the
members of a four-generation family and a novel splice
site mutation within the PAX3 gene in intron 5 in all
affected family members but in none of the unaffected
relatives. Zlotogora et al [69] reported homozygosity
of Waardenburg syndrome with a severe phenotype of
Waardenburg syndrome type III, including dystopia
canthorum, partial albinism and severe upper-limb
defects. The proband’s parents were first cousins who
manifested only a mild form of Waardenburg syndrome
type I. Aymé and Philip [70] reported anencephaly,
arthrogryposis, a small ventricular septal defect, im-
perforate anus, and skeletal dysplasia in a fetus with
possible homozygous Waardenburg syndrome. The
parents were a brother and a sister, both of whom 
had Waardenburg syndrome.
Folic Acid Antagonists
Folic acid antagonists include valproic acid, ami-
nopterin, methotrexate, carbamazepine, phenobarbi-
tal, phenytoin, primidone, sulfasalazine, triamterene,
and trimethoprim. Most members of the folic acid
antagonists seem to induce NTDs, except phenobarbi-
tal and phenytoin [71]. NTDs occur in 1–2% of infants
exposed to valproic acid during early pregnancy [72].
In utero exposure to carbamazepine without concur-
rent exposure to valproic acid carries a 1% risk of spina
bifida [73,74]. Hernández-Díaz et al [71] observed a
more than sixfold increased risk in NTDs after carba-
mazepine exposure and a more than fourfold
increased risk in NTDs after trimethoprim exposure. In
a meta-analysis of 1,255 exposures of carbamazepine,
Matalon et al [75] concluded that among infants with
carbamazepine exposure, there is a two- or threefold
increase in the rate of major congenital anomalies
including NTDs, cardiovascular anomalies, urinary
tract anomalies and cleft palate, and that polytherapy
with a combination of carbamazepine with other
antiepileptic drugs is more teratogenic than carba-
mazepine monotherapy.
Diabetes Mellitus
Chen [76] reported the prenatal diagnosis of lum-
bosacral myelomeningocele, ventriculomegaly, and
Arnold-Chiari malformation type II with a lemon-
shaped calvaria, dislocation of the hip and bilateral
club feet in a 21-week gestation fetus, owing to poor
maternal metabolic control. Mills et al [77] found a
twofold ratio of incidence for spina bifida, hydro-
cephalus and other central nervous system defect and
a threefold ratio of incidence for anencephaly in
infants of diabetic mothers, as compared with those
of the control group. Ray et al [78] found an increased
risk of having a fetus with an open NTD among preges-
tational diabetic women undergoing second-trimester
maternal serum screening. Recently, in the mouse
model of diabetic embryopathy and genotoxicity,
impaired expression of developmental control genes
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has been shown to be a cause of defective morphogen-
esis. For instance, impaired expression of Pax-3, a gene
that regulates neural tube closure, is sufficient to pre-
vent normal formation of the neural tube [79]. Phelan
et al [80] noted that expression of Pax-3 is significantly
reduced in embryos of diabetic mice before the mani-
festation of morphologic defects. Fine et al [81]
showed that hyperglycemia inhibits Pax-3 gene expres-
sion and increases neuroepithelial apoptosis in the
embryo leading to NTDs. Chang et al [82] demon-
strated that oxidative stress in the embryo caused by
maternal hyperglycemia inhibits expression of Pax-3
and contributes to the occurrence of NTDs in diabetic
pregnancy. Pani et al [83] provided evidence for poly-
morphic susceptibility to the molecular causes of
NTDs during diabetic embryopathy. Pani et al [84]
additionally found that Pax-3 regulates neural tube
closure by inhibiting p53-dependent apoptosis.
Loeken [85] concluded that maternal diabetes causes
birth defects such as NTDs by disturbing expression of
genes that control essential developmental process,
and that oxidative stress is involved. Loeken [85] fur-
ther hypothesized that antioxidants, vitamin E, vitamin C,
a combination of antioxidants and lipids, or N-acetyl-
cystein, might have a positive impact on the outcome
of human pregnancy. Loeken [86] summarized the
causes of NTDs resulting from diabetic pregnancy: (1)
maternal diabetes increases glucose concentrations in
maternal circulation, glucose transportation to embryo
cells, and oxidative metabolism in embryo, causing
embryonic oxidative stress; and (2) oxidative stress leads
to decreased expression of Pax3, causing synthesis or
stability of p53 protein, activation of cell death, and
abortion of the neural tube closure process.
Obesity
Obesity is defined as body mass index (BMI) of
≥ 30 kg/m2. Overweight is defined as a BMI of 25.0–
29.9 kg/m2. Compared with normal-weight women,
obese women have an increased risk of infertility, 
miscarriage, chronic hypertension, preeclampsia, throm-
boembolic diseases, sleep apnea, gestational dia-
betes/glucose intolerance, urinary tract infection,
increased incidence of labor induction and cesarean
section, postsurgical wound infection, postpartum
endometritis, and poor lactational outcomes [87].
The possible offspring risks associated with maternal
obesity include NTDs, heart defects, other birth
defects, stillbirth, multiple congenital anomalies,
neonatal death, macrosomia, shoulder dystocia, birth
trauma, meconium aspiration, and juvenile obesity
[87]. Various reports have shown that obese women
have a 1.5- to 3.5-fold risk of having a child with NTDs
than normal-weight women [88–96]. Waller et al [88]
first suggested that obese women are at a higher risk
for producing NTDs (odds ratio, OR, 1.8; 95% confi-
dence interval, CI, 1.1–3.0), especially spina bifida
(OR, 2.6; 95% CI, 1.5–4.5). Watkins et al [93] found
that obese women had almost twice the risk of having
an infant with spina bifida or anencephaly compared
with average-weight women (OR, 1.9; 95% CI, 1.1–3.4).
Werler et al [92] suggested that the risk of NTDs
increases with increasing prepregnant weight, inde-
pendent of the effects of folate intake. They found that
the relative risk of NTDs in the offspring of women
weighing 80–89 kg was 1.9 (95% CI, 1.2–2.9) and the
risk in the offspring of women weighing ≥ 110 kg was
4.0 (95% CI, 1.6–9.9) compared with women who
weighed 50–59 kg. Shaw et al [89] reported an
increase risk for NTD-affected pregnancy among
obese women (OR, 1.9; 95% CI, 1.3–2.9), and the risk
associated with maternal obesity was greater for spina
bifida than for anencephaly. Shaw et al [90] revealed a
positive association between NTD risk and maternal
prepregnant BMI and a negative association between
NTD risk and maternal height. Hendricks et al [95]
observed that both hyperinsulinemia and obesity were
related to increased NTD risk (OR, 1.91; 95% CI,
1.21–3.01; and OR, 1.73; 95% CI, 1.03–2.92, respec-
tively) and suggested that hyperinsulinemia is a strong
risk factor for NTDs in obese women. Watkins et al
[94] found that obese women were more likely than
average-weight women to have infants with spina
bifida (OR, 3.5; 95% CI, 1.2–10.3), omphalocele (OR,
3.3; 95% CI, 1.0–10.3), congenital heart defects 
(OR, 2.0; 95% CI, 1.2–3.4), and multiple anomalies
(OR, 2.0; 95% CI, 1.0–3.2), and overweight women
were more likely than average-weight women to have
infants with congenital heart defects (OR, 2.0; 95% CI,
1.2–3.1) and multiple anomalies (OR, 1.9; 95% CI,
1.1–3.4). Watkins et al [94] recommended obesity pre-
vention efforts in reproductive-aged women before they
become pregnant. Shaw et al [91] found that elevated
NTD risks were associated with maternal intakes of
periconceptional diets having higher glycemic index values
and higher sucrose content, and that no increased
NTD risks were associated with higher intakes of glu-
cose and fructose. Anderson et al [96] found that
obese women had increased risks of delivering off-
spring with anencephaly (OR, 2.3; 95% CI, 1.2–4.3),
spina bifida (OR, 2.8; 95% CI, 1.7–4.5) or isolated
hydrocephalus (OR, 2.7; 95% CI, 1.5–5.0) but not holo-
prosencephaly (OR, 1.4; 95% CI, 0.5–3.8), and sug-
gested that maternal obesity and gestational diabetes
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may increase the risk of central nervous system birth
defects through the joint of causal mechanisms.
Conclusion
This article provides a comprehensive review of syn-
dromes, disorders, and maternal risk factors associ-
ated with NTDs, such as ACLS, autosomal dominant
brachydactyly-clinodactyly syndrome, Manouvrier syn-
drome, SRPS, Disorganization (Ds)-like human malfor-
mations, isolated hemihyperplasia, X-linked NTDs,
meroanencephaly, schisis association, diprosopus,
FVS, DGS/VCFS, Waardenburg syndrome, folic acid
antagonists, diabetes mellitus, and obesity. NTDs
associated with syndromes, disorders, and maternal
risk factors are a rare but important cause of NTDs.
The recurrence risk and the preventive effect of mater-
nal folic acid intake in NTDs associated with syn-
dromes, disorders, and maternal risk factors may be
different from those of non-syndromic multifactorial
NTDs. Perinatal identification of NTDs should alert
one to the syndromes, disorders, and maternal risk
factors associated with NTDs, and prompt a thorough
etiologic investigation and genetic counseling.
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